×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
GlobeNewswire
AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical...
1 day ago
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
GlobeNewswire
AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical...
18 hours ago
Plus Therapeutics secures $18 million in financing deal By Investing.com
Investing.com
AUSTIN, Texas - Plus Therapeutics, Inc. (NASDAQ:PSTV), a clinical-stage pharmaceutical company, announced today it has entered into a...
1 day ago
Plus Therapeutics announces up to $18M private placement financing - TipRanks.com
Tipranks
Plus Therapeutics has entered into a securities purchase agreement with new institutional investors and Company insiders to raise up to...
1 day ago
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Yahoo Finance
Plus Therapeutics Inc (NASDAQ:PSTV) has been selected for $3 million in funding recommendation by the Department of Defense (DoD) office of...
2 weeks ago
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of ...
Bakersfield.com
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline.
2 weeks ago
Plus Therapeutics Full Year 2023 Earnings: Beats Expectations
Yahoo Finance
Plus Therapeutics ( NASDAQ:PSTV ) Full Year 2023 Results Key Financial Results Revenue: US$4.91m (up by US$4.69m from...
2 months ago
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
Yahoo Finance
Plus' CSF-01 cancer cell enumeration test is a sensitive and specific diagnostic test for the presence of adenocarcinoma and melanoma cancer...
1 month ago
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
GlobeNewswire
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline. Funding for pediatric brain cancer...
2 weeks ago
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Yahoo Finance
Began enrollment of the 5th of an anticipated 7 planned dosing cohorts for the ReSPECT-LM Phase 1 dose escalation trial with rhenium (186Re)...
2 months ago